Canada · Health Canada Drug Product Database
LYPHOLYTE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31364
- DIN
- 02139618
- Form
- Solution
- Company as listed by source
- PHARMACEUTICAL PARTNERS OF CANADA INC
- Source status
- Cancelled Post Market (2008-01-10)
- Source last updated
- 2025-03-22
Source-listed ingredients
- SODIUM ACETATE — 2.7 G — per 20 ML
- POTASSIUM CHLORIDE — 2.5 G — per 20 ML
- SODIUM GLUCONATE — 1.1 G — per 20 ML
- MAGNESIUM ACETATE — 860 MG — per 20 ML
- POTASSIUM ACETATE — 690 MG — per 20 ML
- CALCIUM ACETATE — 440 MG — per 20 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 20ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →